Trial intelligence / Profile preview

APPEAR: Albumin vs Plasma for Pediatric Priming

2014-000177-39Phase 4Completed

Sponsor
Policlinico San Donato
Start
Mar 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of albumin (human) in Cardiovascular Malformation (CVM) (2 arms), sponsored by Policlinico San Donato. Primary endpoint: Postoperative bleeding volume. Started Mar 2014; status: completed.

02

Drugs

albumin (human)
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on 2014-000177-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000177-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call